Next Article in Journal
Effects of Photobiomodulation on Osteoarthritis from In Vivo and In Vitro Studies: A Narrative Review
Previous Article in Journal
Bio Meets Nano: Protein Exchange in Saline Biocoronae on Magnetic Nanoparticles
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194

by
Marcin Sokołowski
1,2,*,
Anna Sokołowska
1,
Magdalena Chrząszcz
1 and
Aleksandra Butrym
1,3
1
Dr Alfred Sokołowski Specialist Hospital in Walbrzych, 58-309 Walbrzych, Poland
2
Lower Silesian Oncology, Pulmonology and Hematology Center, pl. Hirszfelda 12, 53-413 Wroclaw, Poland
3
Department of Cancer Prevention and Therapy, Wroclaw Medical University, ul Borowska 2-13, 50-556 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(18), 8993; https://doi.org/10.3390/ijms26188993
Submission received: 2 September 2025 / Accepted: 9 September 2025 / Published: 16 September 2025
(This article belongs to the Section Biochemistry)
In the original publication [1], there was a mistake in the Funding section of this review. The authors would like to change the Funding information from “This research was funded by supported by a grant of the Medical Research Agency KPOD.07.07-IW.07-0321/24.” to “This research received no external funding.” The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The Funding section should be corrected as follows.

Funding

This research received no external funding.

Reference

  1. Sokołowski, M.; Sokołowska, A.; Chrząszcz, M.; Butrym, A. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sokołowski, M.; Sokołowska, A.; Chrząszcz, M.; Butrym, A. Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194. Int. J. Mol. Sci. 2025, 26, 8993. https://doi.org/10.3390/ijms26188993

AMA Style

Sokołowski M, Sokołowska A, Chrząszcz M, Butrym A. Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194. International Journal of Molecular Sciences. 2025; 26(18):8993. https://doi.org/10.3390/ijms26188993

Chicago/Turabian Style

Sokołowski, Marcin, Anna Sokołowska, Magdalena Chrząszcz, and Aleksandra Butrym. 2025. "Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194" International Journal of Molecular Sciences 26, no. 18: 8993. https://doi.org/10.3390/ijms26188993

APA Style

Sokołowski, M., Sokołowska, A., Chrząszcz, M., & Butrym, A. (2025). Correction: Sokołowski et al. Immune Checkpoint Inhibitors (ICI) in Urological Cancers: A New Modern Era, but Not Generally Applied. Int. J. Mol. Sci. 2025, 26, 7194. International Journal of Molecular Sciences, 26(18), 8993. https://doi.org/10.3390/ijms26188993

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop